Leukemia Clinical Trials in Pennsylvania

Showing 1441-1460 of 1,719 trials

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

NCT00058331

RATIONALE: Epoetin alfa may stimulate red blood cell production and treat anemia in patients with solid tumors. It is not yet known whether epoetin alfa given once a week is more effective than epoetin alfa given once every 3 weeks in treating anemia. PURPOSE: Randomized phase III trial to study the effectiveness of epoetin alfa in treating anemia in patients who have solid tumors.

AnemiaLeukemiaLymphoma+4 more

Alliance for Clinical Trials in Oncology365 participantsStarted Jun 2003

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Peoria, Illinois, United States +15 more locations

TERMINATEDPhase 371 miles

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

NCT01798485

The purpose of this study is to determine whether combining ganetespib (STA-9090) with docetaxel is more effective than docetaxel alone in the treatment of patients with advanced non-small cell lung cancer.

Non-Small-Cell Lung AdenocarcinomaNon-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV+1 more

Synta Pharmaceuticals Corp.696 participantsStarted Apr 2013

Flagstaff, Arizona, United States • Prescott Valley, Arizona, United States • Sedona, Arizona, United States +264 more locations

Epoetin Alfa in Treating Anemia in Patients With Solid Tumors

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Leukemia Trials in Other Cities

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)

An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

Metronomic Chemotherapy in Advanced Gastric Cancer

Other Conditions in Pennsylvania